Clinical Trial Update: Optimal Antiplatelet and Lipid Therapy in ACS With DES: OPACT Trial [NA]

View source ↗

Summary

Clinical trial update for the OPACT trial evaluating optimal antiplatelet and lipid therapy in acute coronary syndrome treated with drug-eluting stents. The stu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease
• Coronary Syndrome

Snippet

Sponsor: Yonsei University | Conditions: Coronary Artery Disease | NA | Status: NOT_YET_RECRUITING